Rituximab versus azathioprine as therapy for maintenance of remission for anti-Neutrophil cytoplasm antibody-Associated vasculitis (RITAZAREM): Study protocol for a randomized controlled trial

and on behalf of the RITAZAREM Investigators

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab versus azathioprine as therapy for maintenance of remission for anti-Neutrophil cytoplasm antibody-Associated vasculitis (RITAZAREM): Study protocol for a randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences